Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,...
Reexamination Certificate
2011-05-17
2011-05-17
Bunner, Bridget E (Department: 1647)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
C424S143100, C424S145100, C424S158100, C514S001100
Reexamination Certificate
active
07943131
ABSTRACT:
CXCR3 agonists, including natural CXCR3 ligands, promote bone marrow regeneration, increase peripheral white blood cells, and increase survival if administered prior to treatment of a subject with chemotherapy or radiotherapy. Similar effects are obtained by administering an CXCR3 antagonists following chemotherapy radiotherapy. Compositions and methods are presented for the treatment of cancer and bone marrow diseases.
REFERENCES:
patent: WO 03/024404 (2003-03-01), None
patent: WO2008/116347 (2008-10-01), None
Kouroumalis, The Journal of Immunology, 2005, vol. 175, pp. 5403-5411.
Phillips, A., J Pharm Pharmacology, 2001, vol. 53, pp. 1169-1174.
Pirollo et al. Cancer Res. 2008, vol. 68, No. 5, pp. 1247-1250.
Vidal et al. European Journal of Cancer, 2005, vol. 41, pp. 2812-2818.
U.S. Appl. No. 12/530,579, filed Mar. 26, 2007, Han et al.
Farber, J.M., “A macrophage mRNA selectively induced by γ-interferon encodes a member of the platelet factor 4 family of cytokines”,Proc. Natl. Acad. Sci. USA, vol. 87, pp. 5238-5242, Jul. 1990.
Gasperini, S. et al., “Gene Expression and Production of the Monokine Induced by IFN-γ (MIG), IFN-Inducible T Cell α Chemoattractant (I-TAC), and IFN-γ-Inducible Protein-10 (IP-10) Chemokines by Human Neutrophils”,Journal of Immunology, vol. 162, No. 8, pp. 4928-4937, Apr. 15, 1999.
Gorbachev, A.V. et al., “CXC Chemokine Ligand 9/Monokine Induced by IFN-γ Production by Tumor Cells is Critical for T Cell-Mediated Suppression of Cutaneous Tumors”,The Journal of Immunology, vol. 178, No. 4, pp. 2278-2286, 2007.
Gosling, J. et al., “Molecular uncoupling of C-C chemokine receptor 5-induced chemotaxes and signal transduction from HIV-1 coreceptor activity”,Proc. Natl. Acad. Sci. USA, vol. 94, pp. 5061-5066, May 1997.
Han, W. et al., “Local signals in stem cell-based bone marrow regeneration”,Cell Research, vol. 16, pp. 189-195, 2006.
International Search Report and Written Opinion for International Application No. PCT/CN2007/000971 mailed Feb. 14, 2008.
Jinquan, T. et al., “CXC chemokine receptor 3 expression on CD34+hematopoietic progenitors from human cord blood induced by granulocyte-macrophage colony-stimulating factor: chemotaxis and adhesion induced by its ligands, interferon γ-inducible protein 10 and monokine induced by interferon γ”,Blood Journal, vol. 96, No. 4, pp. 1230-1238, Aug. 15, 2000.
Lazzeri, E. et al., “CXCR3-binding Chemokines: Novel Multifunctional Therapeutic Targets”,Current Drug Targets—Immune, Endocrine&Metabolic Disorders, vol. 5, pp. 109-118, 2005.
Liao, F. et al., “Human Mig Chemokine: Biochemical and Functional Characterization”,J. Exp. Med., vol. 182, pp. 1301-1314, Nov. 1995.
Loos, T. et al., “TLR ligands and cytokines induce CXCR3 ligands in endothelial cells: enhanced CXCL9 in autoimmune arthritis”,Laboratory Investigation, vol. 86, pp. 902-916, 2006.
Rollins, B.J., “Chemokines”,Blood Journal, vol. 90, No. 3, pp. 909-928, 1997.
Ruehlmann, J. M. et al., MIG (CXCL9) Chemokine Gene Therapy Combines with Antibody-Cytokine Fusion Protein to Suppress Growth and Dissemination of Murine Colon Carcinoma:,Cancer Research, vol. 61, pp. 8498-8503, Dec. 1, 2001.
Yun, J.J. et al., “The Role of MIG/CXCL9 in Cardiac Allograft Vasculopathy”,American Journal of Pathology, vol. 161, No. 4, Oct. 2002.
Zhang, R. et al., “Combination of MIG (CXCL9) chemokine gene therapy with low-dose cisplatin improves therapeutic efficacy against murine carcinoma”,Gene Therapy, vol. 13, pp. 1263-1271, 2006.
Han Wei
Lu Huili
Xiang Di
Bunner Bridget E
Foley & Lardner LLP
General Regeneratives Holdings, Inc.
Hamud Fozia M
LandOfFree
Methods for protecting and regenerating bone marrow using... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for protecting and regenerating bone marrow using..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for protecting and regenerating bone marrow using... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2682266